These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29449011)

  • 1. EMA recommendation to suspend HES is hazardous.
    Annane D; Fuchs-Buder T; Zoellner C; Kaukonen M; Scheeren TWL
    Lancet; 2018 Feb; 391(10122):736-738. PubMed ID: 29449011
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyethyl starch solutions and patient harm.
    Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K
    Lancet; 2018 Feb; 391(10122):736. PubMed ID: 29449012
    [No Abstract]   [Full Text] [Related]  

  • 3. [EMA-decision on HES-restrictions].
    Svensén C; Hjelmqvist H
    Lakartidningen; 2014 Jan 8-14; 111(1-2):20. PubMed ID: 24498715
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyethyl starch: here today, gone tomorrow.
    Nolan JP; Mythen MG
    Br J Anaesth; 2013 Sep; 111(3):321-4. PubMed ID: 23946354
    [No Abstract]   [Full Text] [Related]  

  • 5. EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients.
    Mayor S
    BMJ; 2013 Oct; 347():f6197. PubMed ID: 24126958
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of HES 130/0.4 not yet settled.
    Farag E; Argalious M; O'Hara J; Doyle DJ
    Anesth Analg; 2013 Aug; 117(2):528-9. PubMed ID: 23881376
    [No Abstract]   [Full Text] [Related]  

  • 7. Infusion of hydroxyethyl starch-containing fluids.
    Aubron C; Bellomo R
    Minerva Anestesiol; 2013 Sep; 79(9):1088-92. PubMed ID: 24042155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international review of HES.
    Riou B; Cittanova ML
    Intensive Care Med; 1999 Nov; 25(11):1340-1. PubMed ID: 10654230
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxyethyl starch: putting patient safety first.
    Bion J; Bellomo R; Myburgh J; Perner A; Reinhart K; Finfer S
    Intensive Care Med; 2014 Feb; 40(2):256-259. PubMed ID: 24352482
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of HES, dextran and gelatin on kidney function].
    Vogt N; Brinkmann A; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):268-70. PubMed ID: 9617430
    [No Abstract]   [Full Text] [Related]  

  • 11. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
    [No Abstract]   [Full Text] [Related]  

  • 12. Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
    Bellomo R; Bion J; Finfer S; Myburgh J; Perner A; Reinhart K;
    Br J Anaesth; 2014 Mar; 112(3):595-600. PubMed ID: 24535531
    [No Abstract]   [Full Text] [Related]  

  • 13. The nephrotoxicity of 6% Hydroxyethyl Starch 130/0.4 in surgery.
    Kancir AS
    Acta Anaesthesiol Scand; 2016 Apr; 60(4):548-9. PubMed ID: 26941118
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydroxyethyl starch. Reply].
    Rehm M
    Anaesthesist; 2013 Nov; 62(11):928-30. PubMed ID: 24416780
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable creatinine clearance using large-dose HES versus reduced GFR.
    Neff TA; Stocker R
    Kidney Int; 2004 Mar; 65(3):1111; author reply 1111-2. PubMed ID: 14871435
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrastarch solutions: are they definitely dead?
    Moral V; Aldecoa C; Asuero MS
    Br J Anaesth; 2013 Sep; 111(3):324-7. PubMed ID: 23946355
    [No Abstract]   [Full Text] [Related]  

  • 17. [Decision of the European Medicines Agency on hydroxyethyl starch : Important step towards therapeutic and legal security].
    Zwissler B; Rossaint R
    Anaesthesist; 2013 Nov; 62(11):869-70. PubMed ID: 24275932
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
    Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
    J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European hydroxyethyl starch: a safe and inexpensive alternative to albumin.
    Treib J; Haass A; Schimrigk K
    Anesth Analg; 1997 Sep; 85(3):709. PubMed ID: 9296444
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery.
    Haynes GR
    J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.